AlphaStocks
4.1
Weak

DENTSPLY SIRONA Inc. (XRAY)

Health Care / Health Care Supplies

S&P MidCap 400

$11.66

Below average on several measures. Research carefully.

Weak

Score based on 4 of 5 models — moderate confidence

#821out of 1127 in Health Care

Is DENTSPLY SIRONA Inc. a Good Investment in 2026?

DENTSPLY SIRONA Inc. (XRAY) scores 4.1 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Greenblatt Magic Formula model rates DENTSPLY SIRONA Inc. as Strong (Top half (rank 29%)). However, the Graham model rates it Caution. DENTSPLY SIRONA Inc. ranks #821 out of 1127 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

ROE-42.5Market Cap2BDiv Yield5.6

Valuation

Currently unprofitable — fair value estimate not available.

Fair value estimate not available for this stock.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

6/9

Buffett

Neutral

Business quality & competitive moat

Graham

Caution

Price vs intrinsic value

Lynch

Neutral

Growth rate vs price (PEG)

Greenblatt

Strong

Top half (rank 29%)

Frequently Asked Questions

Is DENTSPLY SIRONA Inc. (XRAY) a good investment?
Based on AlphaStocks' composite analysis, DENTSPLY SIRONA Inc. (XRAY) scores 4.1 out of 10, earning a Weak rating. This score is below average, suggesting caution. Currently unprofitable — fair value estimate not available.
What is DENTSPLY SIRONA Inc.'s Piotroski F-Score?
DENTSPLY SIRONA Inc.'s Piotroski F-Score status is Attractive. The raw score is 6/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is XRAY overvalued or undervalued?
A precise fair value estimate is not available for XRAY. Currently unprofitable — fair value estimate not available.
How does XRAY compare to other Health Care stocks?
DENTSPLY SIRONA Inc. ranks #821 out of 1127 stocks in the Health Care sector, placing it in the top 73% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about XRAY?
AlphaStocks evaluates XRAY using five proven investment models. Piotroski: Attractive; Buffett: Neutral; Graham: Caution; Lynch: Neutral; Greenblatt Magic Formula: Strong. These models are combined into a single composite score of 4.1/10.

Similar Stocks

PARRFTIAZN

Compare XRAY with

XRAY vs PARRXRAY vs FTIXRAY vs AZN

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer